We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MRI Reveals Early Impact of Hypertension on Dementia Risk

By HospiMedica International staff writers
Posted on 11 Jul 2018
A new study shows how magnetic resonance imaging (MRI) can reveal previously undetectable white matter (WM) brain damage induced by hypertension, a major risk factor for dementia.

Researchers at IRCCS Neuromed (Pozzilli, Italy) and Sapienza University (Rome, Italy; www.uniroma1.it) conducted a study involving 42 outpatients (40-65 years of age), of whom 23 were hypertensive and 19 normotensive. More...
The researchers first measured the cognitive performance of study participants with no signs of dementia or structural brain changes (as determined by a neuroradiologist), based on conventional MRI on T1 and AX DP/T2 scans. They then repeated imaging using WM fiber-tracking technology on a GE Healthcare (GE; Little Chalfont, United Kingdom; www.gehealthcare.com) 3T Signa Horizon scanner.

In addition, a blinded, certified psychologist tested cognitive function and looked for any impairment of activities of daily living at baseline. Participants then underwent Montreal Cognitive Assessment (MoCA) neuropsychological testing. When specific MoCA cognitive subdomains were analyzed, the hypertensive group displayed significantly impaired memory, executive function, attention, and language domains, and scored worse on verbal paired-associate learning. Hypertension also appeared to impair executive function, as measured on the Stroop test.

When comparing WM finding between those with and without hypertension, specific signatures for dementia risk among hypertensive patients involved deterioration of projection fibers of the right anterior thalamic radiation (ATR), association fibers of the right superior longitudinal fasciculus (SLF), and callosum fibers of the forceps minor (FMI). The researchers concluded that WM tracking could identify patients in initial stages of brain damage that could benefit from therapies aimed at limiting the transition to dementia and neurodegeneration. The study was published on June 12, 2018, in Cardiovascular Research.

“All hypertensive participants were taking antihypertensive therapy, suggesting that an efficient anti-hypertensive therapy is not sufficient to exclude the onset of vascular dementia or protect the brain from white matter microstructural damage,” said lead author graduate student Lorenzo Carnevale, MSc, of NeuroMed. “Our results point out a big issue in current cardiovascular diseases treatment: We can't ignore the brain. Current therapies are not tailored to ensure at the same time cardiovascular protection and cognitive function protection.”

The ATR is a projection fiber that connects the thalamus's anterior nucleus to the anterior cingulate gyrus and frontal cortex, and ATR damage is associated with impaired memory. The SLF connects the cerebrum parietal and occipital and temporal lobes with the ipsilateral frontal cortices; it facilitates the formation of a bidirectional neural network necessary for cognitive functions, such as attention, memory, emotions, and language. The FMI connects the frontal lobes' lateral and medial surfaces, crosses the midline via the genu of the corpus callosum, and has been linked to processing speed tasks.

Related Links:
IRCCS Neuromed


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Syringe Pump
SP50 Series
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.